Common use of Trial Subject Enrollment Clause in Contracts

Trial Subject Enrollment. Institution and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable.

Trial Subject Enrollment. Each of Institution and Principal Investigator have has agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA approvaland Competent Authority approvals. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable.

Trial Subject Enrollment. Institution and Principal Investigator have has agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable.

Trial Subject Enrollment. Institution Provider and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable.

Trial Subject Enrollment. Institution and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA and regulatory authority approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable. The estimated number of enrolled subjects at the Institution is xxx.

Trial Subject Enrollment. Institution and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or and RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicableapplicable 8.

Trial Subject Enrollment. Institution and Principal Investigator have has agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA and regulatory authority approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable.

Trial Subject Enrollment. Institution and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable. Estimated max. number of Trial Subjects enrolled at the Institution is 10 (ten).

Trial Subject Enrollment. Institution and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC IEC, IRB and/or RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicableapplicable or at any time by providing a written notice to Principal Investigator (email being sufficient).

Trial Subject Enrollment. Institution and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA approvalProtocol. Sponsor may require Institution and Investigator to discontinue Trial Subject subject enrollment at Institution if the total enrollment needed for a multithe Multi-center Center Clinical Trial has been is achieved, if applicable.

Trial Subject Enrollment. Institution and Principal Investigator have agreed agrees to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA and regulatory authority approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center the Trial has been achieved, if applicable.

Trial Subject Enrollment. Institution and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA and regulatory authority approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable.

Trial Subject Enrollment. Institution and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or and RA approval. Sponsor may discontinue Trial Subject enrollment if in accordance with the total enrollment needed for a multi-center Trial has been achieved, if applicableProtocol upon written notice. 8.

Trial Subject Enrollment. Institution Provider and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable. 8.

Trial Subject Enrollment. Institution Provider and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable. Estimated number of enrolled Trial Subjects is .

Trial Subject Enrollment. Institution and Principal Investigator have has agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable. Protocol does not require hospitalization during the course of the Trial.

Trial Subject Enrollment. Institution and Principal Investigator have Provider has agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or RA and regulatory authority approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-multi- center Trial has been achieved, if applicable. It is anticipated that approximately 5 Trial Subjects per year shall be enrolled at Provider.

Trial Subject Enrollment. Institution and Principal Investigator have agreed to enroll Trial Subjects in the Trial in accordance with the Protocol and in accordance with IEC and/or and RA approval. Sponsor may discontinue Trial Subject enrollment if the total enrollment needed for a multi-center Trial has been achieved, if applicable. The estimated number of enrolled subjects at the Institution is. xx.